Artwork

Content provided by The Sociable. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Sociable or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Brain Stimulation Startup Founder Talks Tackling the Opioid Crisis While Navigating Y-Combinator

21:01
 
Share
 

Manage episode 321855391 series 3174661
Content provided by The Sociable. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Sociable or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Episode Description below⬇️

Leave an iTunes review here - https://apple.co/3i60XWu

Subscribe on Youtube here - https://bit.ly/3o1M4Z3

Follow us on your favorite podcast platform here - https://bit.ly/3kTfNkY

Find out more about our sponsor Publicize here - https://bit.ly/3BqDUxc

Mental health and addiction have been longstanding issues across societies around the world. However, in our modern society, as stigma subsides around these issues, conversations and solutions have arisen.

In today’s episode, we speak with Adrien Châtillon, CEO & Founder of Actipulse Neuroscience, a neuro-tech company specialized in the research and engineering of Non-Invasive Brain Stimulation technologies for the treatment of psychiatric and neurological disorders, to get a better understanding of how their company’s technology stands to advance mental health and addiction treatment.

To kick off the show, Châtillon shares the backstory of the two previous startups he founded before Actipulse. The first, a Slack for students, and the second, a French movie startup.

He also discusses the company’s goal to bring this technology from a hospital setting to an at-home setting, to make it more affordable, and how they plan to do this.

Châtillon also highlights how their technology works and how it can help treat depression, smoking addiction and anxiety. Alongside how they intend to use it to slow down Parkison’s and Alzheimer's.

Additionally, he talks about a recent study conducted by the company that saw 9 out of 10 subjects with smoking addiction stop smoking after treatment using its technology.

Châtillon explains how they are targeting the dopamine mechanisms in the brain, and an upcoming second trial, which is currently underway, to help tackle opioid addiction.

Finally, on the topic of addiction, Châtillon shares whether or not this technology might stand to tackle behavioral addictions such as gambling.

And before we wrap up the show, Châtillon shares what it has been like to go through the Y Combinator program and advice for other startups and entrepreneurs that want to be selected for the program.

  continue reading

166 episodes

Artwork
iconShare
 
Manage episode 321855391 series 3174661
Content provided by The Sociable. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Sociable or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Episode Description below⬇️

Leave an iTunes review here - https://apple.co/3i60XWu

Subscribe on Youtube here - https://bit.ly/3o1M4Z3

Follow us on your favorite podcast platform here - https://bit.ly/3kTfNkY

Find out more about our sponsor Publicize here - https://bit.ly/3BqDUxc

Mental health and addiction have been longstanding issues across societies around the world. However, in our modern society, as stigma subsides around these issues, conversations and solutions have arisen.

In today’s episode, we speak with Adrien Châtillon, CEO & Founder of Actipulse Neuroscience, a neuro-tech company specialized in the research and engineering of Non-Invasive Brain Stimulation technologies for the treatment of psychiatric and neurological disorders, to get a better understanding of how their company’s technology stands to advance mental health and addiction treatment.

To kick off the show, Châtillon shares the backstory of the two previous startups he founded before Actipulse. The first, a Slack for students, and the second, a French movie startup.

He also discusses the company’s goal to bring this technology from a hospital setting to an at-home setting, to make it more affordable, and how they plan to do this.

Châtillon also highlights how their technology works and how it can help treat depression, smoking addiction and anxiety. Alongside how they intend to use it to slow down Parkison’s and Alzheimer's.

Additionally, he talks about a recent study conducted by the company that saw 9 out of 10 subjects with smoking addiction stop smoking after treatment using its technology.

Châtillon explains how they are targeting the dopamine mechanisms in the brain, and an upcoming second trial, which is currently underway, to help tackle opioid addiction.

Finally, on the topic of addiction, Châtillon shares whether or not this technology might stand to tackle behavioral addictions such as gambling.

And before we wrap up the show, Châtillon shares what it has been like to go through the Y Combinator program and advice for other startups and entrepreneurs that want to be selected for the program.

  continue reading

166 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide